Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
179.78
+0.83 (0.46%)
Jun 18, 2025, 4:00 PM - Market closed
Quest Diagnostics Stock Forecast
Stock Price Forecast
The 14 analysts that cover Quest Diagnostics stock have a consensus rating of "Buy" and an average price target of $185.07, which forecasts a 2.94% increase in the stock price over the next year. The lowest target is $170 and the highest is $200.
Price Target: $185.07 (+2.94%)
Analyst Consensus: Buy
* Price targets were last updated on May 6, 2025.
Analyst Ratings
The average analyst rating for Quest Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 2 | 3 | 3 | 3 |
Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Hold | 6 | 6 | 7 | 7 | 7 | 7 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 14 | 14 | 13 | 14 | 14 | 14 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Hold Maintains $180 → $190 | Hold | Maintains | $180 → $190 | +5.68% | May 6, 2025 |
Piper Sandler | Piper Sandler | Hold Maintains $180 → $200 | Hold | Maintains | $180 → $200 | +11.25% | Apr 28, 2025 |
Truist Securities | Truist Securities | Hold Maintains $182 → $190 | Hold | Maintains | $182 → $190 | +5.68% | Apr 23, 2025 |
Barclays | Barclays | Hold Maintains $175 → $185 | Hold | Maintains | $175 → $185 | +2.90% | Apr 23, 2025 |
Evercore ISI Group | Evercore ISI Group | Hold Maintains $175 → $180 | Hold | Maintains | $175 → $180 | +0.12% | Apr 23, 2025 |
Financial Forecast
Revenue This Year
10.90B
from 9.87B
Increased by 10.38%
Revenue Next Year
11.34B
from 10.90B
Increased by 4.03%
EPS This Year
9.79
from 7.69
Increased by 27.37%
EPS Next Year
10.64
from 9.79
Increased by 8.61%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 11.4B | 12.0B | 12.6B | ||
Avg | 10.9B | 11.3B | 11.8B | ||
Low | 10.5B | 10.9B | 11.2B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 15.4% | 10.4% | 11.6% | ||
Avg | 10.4% | 4.0% | 3.7% | ||
Low | 6.1% | -0.1% | -0.8% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 10.25 | 11.36 | 12.30 | ||
Avg | 9.79 | 10.64 | 11.47 | ||
Low | 9.43 | 10.09 | 10.70 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 33.3% | 16.0% | 15.6% | ||
Avg | 27.4% | 8.6% | 7.8% | ||
Low | 22.6% | 3.1% | 0.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.